Clinical Trial Update: Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating an exhaled nitric oxide-based treatment for COPD, comparing inhaled corticosteroid/long-acting beta-agonist the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ICS+LABA (inhaled corticosteroid + long-acting beta-agonist)
• LAMA (long-acting muscarinic antagonist)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: COPD | Phase 4 | Status: UNKNOWN